Year: 2013
Type: article
Study design: Observational Study
Authors: Shamsah Kazani, Anna Planaguma, Emiko Ono, Matteo Bonini, Muhammad Zahid, Gautham Marigowda, Michael E. Wechsler, Bruce D. Levy, Elliot Israel
Institutions: Brigham and Women's Hospital, Harvard University
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Amgen, GlaxoSmithKline, Brigham and Women's Hospital, Teva Pharmaceutical Industries, Harvard University, Harvard Catalyst, Sunovion, Eisai, National Institutes of Health, Genentech, National Heart, Lung, and Blood Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Center for Research Resources, National Center for Advancing Translational Sciences
Awards: SCHOLARS IN CLINICAL SCIENCE PROGRAM, G2877577918, Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology, G3431532524, Harvard Clinical and Translational Science Center (UL1), Harvard Clinical and Translational Science Center (KL2), G3740841103, Lipid Mediators in the Resolution of Asthma Exacerbations, G4627662371, G46759241, Lipoxins in Severe Asthma (LIPSA), G5044837842, G5234771832, AMSA: ALXR/FBR Mediated Signaling in Severe Asthma, G6072357826, COUNTER REGULATORY LIPID SIGNALS IN SEVERE ASTHMA, G6438031073, ASTHMA CLINICAL RESEARCH NETWORK, Harvard Clinical and Translational Science Center (KL2), Lipid Mediators In The Resolution of Asthma Exacerbations, G8834031101, G9000254187, G99486532
OpenAlex ID: W2165226870